Attempt to Promote 1,016,000 Amphetamine Pills Thwarted in Taif    Saudi Fund for Development CEO Receives Sierra Leone's Foreign Minister    Public Investment Fund Launches "Savvy Gaming Group"    KSrelief Signs USD 10 Million Worth Agreement with UNICEF to Provide Basic Health Services for Mothers, Children in Yemen    Diriyah E-Prix 2-Time Champion Sam Bird Sets His Sight on More Triumph in 2022 Diriyah E-Prix    Asian Shares Mixed    [email protected]: Set to become world's technological and economic powerhouse    Royal Commission in Yanbu Achieves Arab Award for Operation and Maintenance    Minister of Islamic Affairs sponsors closing ceremony of 34th Virtual International Conference for Muslims of Latin America and Caribbean    IPA organizes 'Innovation and the Future of Government Work' conference on February 9    NDMC clears 43% of debts due for payment in 2022    Flying car cleared for takeoff, but you'll need a pilot's license    15% jump in number of Saudis working in private healthcare sector    Crown Prince, Chan-o-cha reaffirm need to open a new chapter in Saudi-Thai relations    Dozens feared lost as 'smuggling' boat capsizes off Florida    Netherlands to ease Covid restrictions despite rising case numbers    What the grand Republic Day parade means to India    Unvaccinated man denied heart transplant by Boston hospital    Deputy Ruler of Sharjah witnesses premiere of 'Narratives of the Place'    Sir Elton John postpones US shows after positive Covid-19 test    Bollywood's Shilpa Shetty cleared of obscenity over Richard Gere kiss    Egypt Records 1809 New Cases of COVID-19    Commerce Minister: Prime Minister of Thailand visit comes within Saudi Arabia's keenness to strengthen relations with countries of world    Minister of Justice Meets with His British Counterpart    Non-oil exports in Saudi Arabia increase by 26.1%    At least six killed in Cameroon stadium stampede    Al Hilal pays tribute to departing star striker Bafetimbi Gomis    Saudi Stock Exchange Main Index Ends Trading Higher at 12,108 Points    General Court of Audit President Inaugurates 8th Conference for Internal Audit with Int'l Participation    UN chief calls for Olympic Truce to build 'culture of peace' through power of sport    Taylor Swift slams Damon Albarn over songwriting comments    Australian Open: Peng Shuai T-shirt ban reversed after outcry    Cirque du Soleil to establish an academy and regional office in Saudi Arabia    Omani National Football Team Arrives in Jeddah to Meet Saudi National Team    'Bab Al Hara' Director Bassam AlMulla passes away at 65    Saudi Handball Team Loses to Qatar in Main Round of 2022 Asian Men's Handball Championship    Eighth Season of ABB FIA Formula E World Championship to kick off in Diriyah    Riyadh's Qualitative Events Enrich its Winter, Attract World Attention    SFDA: Fat is a Source of Energy and Its Abundance is Linked to Chronic Diseases    Reflections on celebration of Christmas    Royal Commission for AlUla to Hold Custodian of the Two Holy Mosques Endurance Cup 2022, Richard Mille AlUla Desert Polo    Saudi Arabia's Pavilion at Expo 2020 Dubai Organizes a Dance Theatrical Show for Children    Saudi Arabia rebuffs UN resolution on 'sexual orientation'    Kabir Khan eyes on joint Indian – Saudi film projects    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



India approves AstraZeneca and local COVID-19 vaccines
Published in The Saudi Gazette on 03 - 01 - 2021

India's drugs regulator on Sunday gave final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech and a state-run institute, Reuters reported.
The decisions mark the first vaccine approvals for the world's second-most populous country, which after the United States, has recorded the most infections of the coronavirus disease.
It is now expected to start a massive immunization program within about a week, a government official said, and hopes to inoculate 300 million of its 1.35 billion people free of charge in the first six to eight months of this year.
The drugs regulatory authority gave the green light to the jabs developed by AstraZeneca with Oxford University and by local firm Bharat Biotech. Prime Minister Narendra Modi called it "a decisive turning point".
On Saturday, India held nationwide drills to prepare more than 90,000 health care workers to administer vaccines across the country, which has a population of 1.3 billion people.
The Drugs Controller General of India said both manufacturers had submitted data showing their vaccines were safe to use.
The Oxford/AstraZeneca vaccine is being manufactured locally by the Serum Institute of India, the world's largest vaccine manufacturer. It says it is producing more than 50 million doses a month.
Adar Poonawalla, the company's CEO, told the BBC in November that he aimed to ramp up production to 100 million doses a month after receiving regulatory approval.
The jab, which is known as Covishield in India, is administered in two doses given between four and 12 weeks apart.
It can be safely stored at temperatures of 2C to 8C, about the same as a domestic fridge, and can be delivered in existing health care settings such as doctors' surgeries.
This makes it easier to distribute than some of the other vaccines. The jab developed by Pfizer/BioNTech - which is currently being administered in several countries — must be stored at -70C and can only be moved a limited number of times — a particular challenge in India, where summer temperatures can reach 50C.
The local vaccine, however, was approved despite the absence of data on how efficient it can be. It has yet to go through large-scale trials.
The Drugs Controller General, V.G. Somani, said Bharat Biotech's Covaxin was "safe and provides a robust immune response".
Somani said it had been approved "in public interest as an abundant precaution, in clinical trial mode, to have more options for vaccinations, especially in case of infection by mutant strains".
Pfizer, whose vaccine has already been approved for use in jurisdictions including the UK, the US and the EU, is also seeking emergency authorization in India. In all, some 30 vaccine candidates are being developed in India.. — Agencies


Clic here to read the story from its source.